B&K (HKSE:02396) Beneish M-Score

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02396 B&K Corp Ltd HKSE:02396
8 GF Score
Price HK$3.75
! 1 Warning Sign
View Full Analysis

What is B&K Beneish M-Score?

B&K does not have enough data to calculate Beneish M-Score.

B&K Beneish M-Score Historical Data

* Premium members only.

The historical data trend for B&K's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

B&K Beneish M-Score Chart

B&K Annual Data
Trend Dec23 Dec24 Dec25
Beneish M-Score
0.00 0.00 -1.48

B&K Quarterly Data
Dec23 Dec24 May25 Sep25 Dec25
Beneish M-Score 0.00 0.00 0.00 0.00 -1.48

HKSE:02396 vs VRTX, REGN, RVMD: Beneish M-Score Comparison

For the Biotechnology subindustry, B&K's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

B&K Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, B&K's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where B&K's Beneish M-Score falls into.


HKSE:02396
8GF Score
B&K Corp Ltd HKSE:02396
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

B&K Business Description

Address No. 19 Qinling Road, Xiexin Center, Room 1507, Building 1, Laoshan District, Shandong Province, Qingdao, CHN
B&K Corp Ltd is a China-based biopharmaceutical company committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The company prominently focuses on the discovery, development and commercialization of therapies for wound healing, currently PDGF drugs. Its pipeline consisted of ten candidates, seven of which are PDGF candidates, including two Core Products, namely Pro-101-1 for the treatment of thermal burns and Pro-101-2 for the treatment of DFUs, which are rhPDGF-BB drugs. The company operates in a single reportable segment: the research and development of biopharmaceutical products. Geographically, the company generates all its revenue from Chinese Mainland.
8GF Score

Get the complete analysis for HKSE:02396

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.75
Price